Cognizant’s digital expertise is solving some of today’s most pressing challenges for pharmaceutical, biotech and medical device companies. This is an introduction to how AI, robotics, automation, IoT and other technologies can improve productivity, enhance drug safety and ensure regulatory compliancy.
Learn how 11 organizations use AI to accelerate decision making, improve business processes and drive growth. Fill the form to download white paper.
To get ahead in the industrial space amid the prolonged pandemic, manufacturers must embrace holistic agility and resilience, and democratize access to applications and data. This whitepaper provides a roadmap ahead.
Covid-19 served as a wake-up call to manufacturers – one that has accelerated the need for digitalization. To find out what technology investments will propel manufacturers forward, we conducted ESI ThoughtLab. Learn more in our e-Book.
IoT initiatives offer enormous opportunities for companies to adapt and remain resilient in a rapidly evolving operating environment, like the one we are currently experiencing. However, many IoT initiatives are trapped in the innovation basement, while it should really be an enterprise matter. Learn more in this whitepaper.
Even before the pandemic, work in all its forms was poised to change. Now, the future-forward script for businesses has crystallized: flexible, dataintensive and digitally oriented ways of working will be indispensable. Learn more in a new survey.
The ongoing pandemic has created a global shortage of life-saving drugs and supplies, just as social distancing has hampered the life sciences supply chain. Meanwhile, the postponement of nonessential procedures has reduced demand for products such as those used for vaccinations and ophthalmology. How should life sciences companies respond?
Five technology trends – AI and automation, human augmentation, edge analytics/ processing, data ownership and protection, and the intermingling of products and services – are currently changing the life sciences industry.
WHO believes that 80% of all visual impairment caused by Diabetic Retinopathy can be cured with regular screening and early detection. Follow our journey in developing an AI-based diagnostic tool to speed up DR identification.
How do you engage with new competence and capacity outside company walls, without risking your own business? Learn how LEO Pharma successfully opened up parts of its research for external collaboration to pave the way for drug innovation at speed. The secret? Trust, respect and engagement, with no strings attached; you simply can’t push a “big brother attitude” on true collaborations.
As a life sciences company wanted to automate a highly manual process that was becoming a quality-control risk and a regulatory burden, Cognizant helped them build a robotic process automation (RPA) solution that addresses the immediate issues – and that will now also be leveraged in other parts of the organization.
New technologies are rapidly creating numerous opportunities for life sciences companies to improve productivity, enhance patient care and ensure regulatory compliance. Cognizant has been involved in many interesting projects across the globe, and this is a brief introduction to four of them.
How can the finance department use analysis to promote and drive business development? It is all about utilising the goldmine that is data in a smarter way. Key performance indicators play a decisive role in realising analysis that creates more value.
Cognizant is redefining the way life sciences companies do digital. That’s why all 30 of the top 30 global pharmaceutical companies, 9 of the top 10 biotech companies and 12 of the top 15 medical device companies work with us.
or send us a message
Ladda ned artikeln genom att fylla i fältet nedan!